HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

HHS’s COVID-19 PHE Extension Brings Continued Relief

July 30, 2020 by David Kopf

HHS extended the COVID-19 Public Health Emergency (PHE) for another 90 days, effective July 25, and the American Association for Homecare outlined the various forms of relief HME providers can expect to continue as a result.

The continued relief comes from a variety of sources, such as continued CARES Act relief, relaxed regulations from CMS and state Medicaid programs, as well as other payers, and will last at least until Oct. 22.

“Taken together, these measures will help HME suppliers weather revenue losses and increased costs associated with the pandemic, allowing our industry to continue to provide a high level of care and help alleviate the burdens on hospitals and other parts of our healthcare infrastructure,” a statement from AAHomecare read.

AAHomecare noted some specific forms of relief that should continue:

  • Medicare’s 75/25 blended rate for non-rural/non-bid suppliers. The association notes that these areas are receiving rate increases of about 30 percent overall.
  • Medicare’s 50/50 blended rate for rural suppliers will remain in effect until the end of 2020 or the end of the PHE, whichever comes late).
  • The NCD/LCD relaxations that have allowed expanded use of home-based respiratory products and therapy, as well as infusion and anticoagulation devices.
  • The waiving of face-to-face requirements for many products; and the allowance to use telehealth for PMD face-to-face requirement will continue.
  • The 6.2 percent increase in Medicaid FMAP matching. This will remain in effect through the end of the quarter in which the PHE expires, which means this relief will continue until at least the end of 2020.
  • State Medicaid waivers and flexibilities tied to the PHE.
  • TRICARE reimbursement increases tied to the Medicare rate relief.

AAHomecare added that HHS’s PHE extension would likely influence how quickly CMS fully renews audit activities, as well as how other third-party payers determine how long to continue relaxed HME requirements.

The association also reported its Regulatory Council was developing policy recommendations for adopting some of these flexibilities, included expanded telehealth use, on a permanent basis.

Related Articles Read More >

National Ramp Moves to New Headquarters
The new base provides expanded warehouse space, upgraded offices, and improved logistics for National Ramp customers.
Waud Capital Partners to Collaborate with HME Executive Bill Mixon on Platform Investment
Mixon departed Advanced Diabetes Supply Group in July following its sale to Cardinal Health.
O2 Concepts Announces MDR Approval for European Union, Expansion
The company’s Oxlife Liberty POC and Oxlife Independence POC with DNA Technology will be offered in EU member countries.
Briefly: AARC Giving Grants to Members Impacted by Texas Flooding; Fisher & Paykel Schedules Shareholders’ Meeting for Aug. 21
Featuring the American Association for Respiratory Care and Fisher & Paykel Healthcare Corp.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
continuum event
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe